Verified Supplement Data Primary-sourced

BCAA Dosage: The 2-3g Leucine "Trigger" and Why More Isn't the Point

By Erin Rose · Updated · Methodology

Educational summary — not medical advice. People with Maple Syrup Urine Disease (MSUD) must not take BCAA supplements. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

The honest answer

5-10g/day is the typical retail range, most often split into a 5g dose pre- and/or post-workout. A 5g dose at the standard 2:1:1 ratio delivers about 2.5g leucine — right at the 2-3g "leucine trigger" threshold thought to meaningfully activate muscle protein synthesis. But the number that actually matters more is your total daily protein: whey, meat, and eggs already deliver leucine past that threshold as part of a complete amino acid profile, so a separate BCAA product is solving a problem most adequately-fed people don't have.

Typical retail dose5-10gper day, split pre/post-workout
Leucine trigger2-3gper dose, to meaningfully activate mTOR
No established UL5-20gwell-studied range across trials, not a ceiling

Why the standard 2:1:1 ratio gets you to the leucine trigger at 5g

BCAAs are typically sold at a 2:1:1 ratio — 2 parts leucine to 1 part each isoleucine and valine — so a 5g BCAA serving delivers roughly 2.5g of leucine. Norton & Layman 2006 describes the mechanism: exercise increases BCAA oxidation and lowers plasma leucine, inhibiting the translation-initiation factors that drive protein synthesis; restoring leucine (via protein or a leucine-containing supplement) activates the mTOR pathway synergistically with insulin. Churchward-Venne et al. 2014 put a number on it empirically: in a 40-man RCT, a low-protein (6.25g) beverage matched a 25g whey dose's myofibrillar protein synthesis response only once boosted to 5.0g total leucine — a low-total-protein beverage can partially compensate with added leucine, but this is a leucine-dose-response finding, not proof that isolated BCAAs match whole protein gram-for-gram. Some retail blends go "leucine-heavy" at 3:1:1, 4:1:1, or 8:1:1 ratios; these have less standalone evidence than the standard 2:1:1 products in this comparison.

Reference pointAmountWhat it means
Typical retail dose5-10g/dayMost common label range, often split pre/post-workout (Jackman 2017 used a single 5.6g dose)
Leucine trigger2-3g leucine/doseThreshold generally cited to activate mTOR (Norton & Layman 2006 mechanism; Churchward-Venne 2014 empirical support)
DOMS/recovery trial doses~100mg/kg to 255mg/kg/day~7g to 17-18g/day for a 70kg adult; Weber 2021's own hedge is that doses above 255mg/kg/day are NOT shown to be more effective
Cirrhosis/clinical doseDefined 1-year medical protocolMarchesini 2003 — a medically supervised advanced-cirrhosis protocol, NOT a consumer/retail dosing reference
No established Upper Limit5-20g spans the trials reviewedNo formal Tolerable Upper Intake Level for BCAAs; treat this as the well-studied range, not a hard ceiling

Timing: pre-loading beats dosing only after the workout

The strongest single-trial soreness signal in this evidence base came from dosing BEFORE the damaging exercise bout. Shimomura et al. 2010 gave BCAA at 100mg/kg body weight before a squat protocol and found significantly lower soreness and smaller force loss at Day 3 vs. placebo. Several of the meta-analyses in this evidence base note this timing pattern — pre-loading appears to matter, not just total daily dose. If you're going to try a BCAA product for soreness, the trial evidence supports taking it before training, not only afterward.

The central honest point: whole protein already gets you there

This is worth repeating plainly, not burying: someone eating 1.3-1.8g/kg/day of total protein across 3-4 meals — the range Phillips & Van Loon 2011 cite to maximize muscle protein synthesis — is very likely already meeting or exceeding these BCAA and leucine thresholds without a separate product. Whey, meat, eggs, and most protein powders deliver BCAAs as part of a complete amino acid profile, including all 6 of the other essential amino acids that BCAA-only products don't supply and that are required to sustain new muscle protein synthesis past the initial window. A BCAA supplement is not solving a nutritional gap for someone who is already protein-adequate.

Safety: no established Upper Limit, and one absolute contraindication

No formal Tolerable Upper Intake Level exists for BCAAs in this evidence base. The trials reviewed here span roughly 5-20g/day without serious adverse events reported at the healthy-adult level; GI upset can occur at the higher end. BCAAs are absolutely contraindicated for people with Maple Syrup Urine Disease (MSUD), a rare inherited disorder of BCAA metabolism — a well-established clinical fact, not a hedge. For pregnancy and breastfeeding, this evidence pack has no dedicated supplement-safety trial data; the default is food-first nutrition and a conversation with a clinician, not a specific danger signal found in the literature reviewed here.

Picks by dose

Full ranking by cost per gram is on best BCAA.

Cheapest per gram (best for gram-scale doses)BulkSupplements BCAA 2:1:1 Powder (500 g)

At a 5g dose, this powder costs about $0.25/day — but its 1g labeled scoop means 5 scoops to get there.

As an Amazon Associate we earn from qualifying purchases. Of 5 products tracked; ranked by cost per gram, never commissions.

Frequently asked questions

How much BCAA should I take?

5-10g/day is typical, most often split 5g pre/post-workout — but check your total protein intake first.

What is the leucine trigger?

~2-3g leucine per dose to meaningfully activate mTOR (Norton & Layman 2006; Churchward-Venne 2014). A 5g BCAA dose delivers about 2.5g leucine.

Do I need more BCAA if I eat enough protein?

No — whole protein already delivers BCAAs, including leucine past the trigger, as part of a complete amino acid profile.

Is there an upper limit?

No formal UL exists. Trials span 5-20g/day. MSUD is an absolute contraindication.

Related

Sources

  1. Norton LE, Layman DK. "Leucine regulates translation initiation of protein synthesis in skeletal muscle after exercise." J Nutr. 2006. PMID: 16424142
  2. Churchward-Venne TA, et al. "Leucine supplementation of a low-protein mixed macronutrient beverage enhances myofibrillar protein synthesis in young men: a double-blind, randomized trial." Am J Clin Nutr. 2014. PMID: 24284442
  3. Phillips SM, Van Loon LJ. "Dietary protein for athletes: from requirements to optimum adaptation." J Sports Sci. 2011. PMID: 22150425
  4. Jackman SR, et al. "Branched-Chain Amino Acid Ingestion Stimulates Muscle Myofibrillar Protein Synthesis following Resistance Exercise in Humans." Front Physiol. 2017. PMID: 28638350
  5. Weber MG, et al. "The use of BCAA to decrease delayed-onset muscle soreness after a single bout of exercise: a systematic review and meta-analysis." Amino Acids. 2021. PMID: 34669012
  6. Shimomura Y, et al. "Branched-chain amino acid supplementation before squat exercise and delayed-onset muscle soreness." Int J Sport Nutr Exerc Metab. 2010. PMID: 20601741
  7. Marchesini G, et al. (Italian BCAA Study Group). "Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial." Gastroenterology. 2003. PMID: 12806613
  8. Full product dataset: /branched-chain-amino-acids/cost-by-brand.json (CC BY 4.0).